Veradermics Inc
MANEHealthcare|Biotechnology|USA
$119.60
-5.31 (-4.25%)
Tangible Book
$10.46
About
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.
Stock Price
+216.8%(1Y)
Pipeline Summary
5 total trials0
Phase 1
3
Phase 2
3
Phase 3
0
Phase 4
Active: 3Recruiting: 1Completed: 1
Active Trials (4)
Efficacy and Safety of VDPHL01 in Males With AGA
NCT06724614Androgenetic Alopecia
Phase 2Phase 3Active
Enrollment: 480 participants
Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)
NCT07146022Androgenetic Alopecia (AGA)
Phase 3Recruiting
Enrollment: 552 participants
Safety and Efficacy of VDPHL01 in Males and Females With AGA
NCT06527365Androgenetic Alopecia
Phase 2Active
Enrollment: 70 participants
Safety and Efficacy of VDPHL01 in Males With AGA
NCT06972264Androgenetic Alopecia
Phase 3Active
Enrollment: 480 participants
BioScore
4.7/10
Cautious
Ownership
Recent Insider Trades
SUVRETTA CAPITAL MANAGEMENT, LLCBUY
2026-02-06282,674 shares @ $37.3
CHILDS JOHN WBUY
2026-02-05294,117 shares @ $17
Coric VladBUY
2026-02-05117,646 shares @ $17
CHILDS JOHN WBUY
2026-02-05294,117 shares @ $17
Longitude Capital Partners V, LLCBUY
2026-02-051,075,000 shares @ $17
Recent News
2026-07-07 16:39:36
2026-06-16 17:31:42
Data last updated: Jul 13, 2026, 12:40 PM